Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

<p>Heterologous prime-boost vaccination with viral vectors simian adenovirus 63 (ChAd63) and Modified Vaccinia Ankara (MVA) induces potent T cell and antibody responses in humans. The 8-week regimen demonstrates significant efficacy against malaria when expressing the pre-erythrocytic malaria...

Full description

Bibliographic Details
Main Authors:	Bliss, C, Bowyer, G, Anagnostou, N, Havelock, T, Snudden, C, Davies, H, de Cassan, S, Grobbelaar, A, Lawrie, A, Venkatraman, N, Poulton, I, Roberts, R, Mange, P, Choudhary, P, Faust, S, Colloca, S, Gilbert, S, Nicosia, A, Hill, A, Ewer, K
Format:	Journal article
Published:	Springer Nature 2018

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP

Similar Items